A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Virtual Tribunal Monastery
Assistance Publique - Hôpitaux de Paris
Washington University School of Medicine
Duke University
Centre Hospitalier Universitaire de Liege
New York Medical College
Duke University
Roswell Park Cancer Institute
RTI International
University of Aberdeen
ASH Research Collaborative
Columbia University
Duke University
Westat
King's College Hospital NHS Trust
University of California, San Diego
Hospital Universitari Vall d'Hebron Research Institute
King's College London
University of California, San Francisco
University of Virginia
University of Milano Bicocca
Xperiome
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
Medical College of Wisconsin
Duke University
Children's Mercy Hospital Kansas City
Georgia State University
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
New York Medical College
American Society of Hematology
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Brigham and Women's Hospital